Chronic obstructive pulmonary disease classification, phenotypes and risk assessment.

Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease. Various classification systems and phenotypes have been proposed. This review highlights the current classifications of COPD, describes the major phenotypes and provides a blue print for risk assessment of COPD. It is likely that more phenotypes and endotypes of COPD will be described paving the way to personalized medicine for patients with COPD.

• Publication year

  2019

• Venue

  Journal of Thoracic Disease

• Publication date

  2019-06-30

• Fields of study

  Medicine

• Identifiers
  DOI 10.21037/JTD.2019.05.10PMID 31632753PMCID PMC6783724
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Editorial: Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Guidelines for COPD, Including COVID-19, Climate Change, and Air Pollution

  2023cited by this paper
• COPD phenotypes: differences in survival

  2018cited by this paper
• Once‐Daily Single‐Inhaler Triple versus Dual Therapy in Patients with COPD

  2018cited by this paper
• Asthma–COPD overlap: identification and optimal treatment

  2018cited by this paper
• COPD Guidelines: A Review of the 2018 GOLD Report

  2018cited by this paper
• Precision medicine in COPD: where are we and where do we need to go?

  2018cited by this paper
• What Should Be the Cutoff Value of Blood Eosinophilia as a Predictor of Inhaled Corticosteroid Responsiveness in Patients with Chronic Obstructive Pulmonary Disease?

  2017cited by this paper
• Spanish Guidelines for Management of Chronic Obstructive Pulmonary Disease (GesEPOC) 2017. Pharmacological Treatment of Stable Phase.

  2017cited by this paper
• Defining the “Frequent Exacerbator” Phenotype in COPD: A Hypothesis‐Free Approach

  2017cited by this paper
• Spanish COPD Guidelines (GesEPOC) 2017. Pharmacological Treatment of Stable Chronic Obstructive Pulmonary Disease

  2017cited by this paper
• Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease

  2017cited by this paper
• Guía española de la enfermedad pulmonar obstructiva crónica (GesEPOC) 2017. Tratamiento farmacológico en fase estable

  2017cited by this paper
• Chronic Obstructive Pulmonary Disease Phenotypes: Implications for Care

  2017cited by this paper
• American Thoracic Society/National Heart, Lung, and Blood Institute Asthma‐Chronic Obstructive Pulmonary Disease Overlap Workshop Report

  2017influential reference
• What does endotyping mean for treatment in chronic obstructive pulmonary disease?

  2017cited by this paper
• Defining the Asthma-COPD Overlap Syndrome in a COPD Cohort.

  2016cited by this paper
• ABC of chronic obstructive pulmonary disease

  2016cited by this paper
• Asthma-COPD Overlap.

  2016cited by this paper
• The asthma–chronic obstructive pulmonary disease overlap syndrome (ACOS): opportunities and challenges

  2015cited by this paper
• Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials.

  2015cited by this paper
• Therapeutic approaches to asthma-chronic obstructive pulmonary disease overlap syndromes.

  2015cited by this paper
• Derivation and validation of clinical phenotypes for COPD: a systematic review

  2015cited by this paper
• Asthma–COPD overlap 2015: now we are six

  2015cited by this paper
• The Asthma COPD Overlap Syndrome (ACOS)

  2015influential reference
• Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study.

  2014cited by this paper
• The impact of exacerbation frequency on mortality following acute exacerbations of COPD: a registry-based cohort study

  2014cited by this paper
• Prof. Denis E. O'Donnell: personalized treatment of COPD.

  2014cited by this paper
• Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthma.

  2014cited by this paper
• High hospital burden in overlap syndrome of asthma and COPD

  2013cited by this paper
• FAQs about the GOLD 2011 assessment proposal of COPD: a comparative analysis of four different cohorts

  2013cited by this paper
• GOLD 2011 disease severity classification in COPDGene: a prospective cohort study.

  2013cited by this paper
• Evolution of the GOLD documents for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Controversies and questions.

  2013cited by this paper
• Beyond FEV 1 in COPD: a review of patient-reported outcomes and their measurement

  2012cited by this paper
• Beyond FEV1 in COPD: a review of patient-reported outcomes and their measurement

  2012cited by this paper
• Two Distinct Chronic Obstructive Pulmonary Disease (COPD) Phenotypes Are Associated with High Risk of Mortality

  2012cited by this paper
• The chronic bronchitic phenotype of COPD: an analysis of the COPDGene Study.

  2011cited by this paper
• Reduction of exacerbations by the PDE4 inhibitor roflumilast - the importance of defining different subsets of patients with COPD

  2011cited by this paper
• Overlap Syndrome of Asthma and COPD Predicts Low Quality of Life

  2011cited by this paper
• Impact of exacerbations on COPD

  2010cited by this paper
• Susceptibility to exacerbation in chronic obstructive pulmonary disease.

  2010cited by this paper
• [Outcome measures].

  2009cited by this paper
• Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials.

  2009cited by this paper
• Cough and sputum production are associated with frequent exacerbations and hospitalizations in COPD subjects.

  2009cited by this paper
• Predictors of Survival in COPD: more than just the FEV1.

  2008cited by this paper
• CHRONIC OBSTRUCTIVE PULMONARY DISEASE Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease

  2005cited by this paper
• Pathogenesis of COPD

  2005cited by this paper
• The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease.

  2004cited by this paper
• Outcome Measures for COPD Treatments: A Critical Evaluation

  2004cited by this paper
• Pathogenesis of COPD.

  2003cited by this paper
• [Respiratory insufficiency].

  2003cited by this paper
• Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD.

  2002cited by this paper
• Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

  2001cited by this paper
• Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments)

  1996cited by this paper
• Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society.

  1995cited by this paper
• The relationship between pulmonary function and dyspnea in obstructive lung disease.

  1989cited by this paper
• Chronic obstructive pulmonary disease: a definition and implications of structural determinants of airflow obstruction for epidemiology.

  1989cited by this paper
• Acute respiratory insufficiency. Treatment with prolonged extracorporeal oxygenation.

  1972cited by this paper
• Respiratory insufficiency.

  1955cited by this paper

• Assessment of the Relationship Between Genetic Determinants of Obesity, Unhealthy Eating Habits and Chronic Obstructive Pulmonary Disease: A Mendelian Randomisation Study

  2024cites this paper
• IgG Antibody Titers Against Ascaris lumbricoides, Strongyloides stercolaris, and Toxocara canis in Venezuelan Patients with Asthma or COPD

  2024cites this paper
• The impact of chronic obstructive pulmonary disease on the risk of immune-related pneumonitis in lung cancer patients undergoing immunotherapy: a systematic review and meta-analysis

  2024cites this paper
• Effect of Inhaler Technique Health Education in Improving Symptoms and Lung Function in COPD Outpatient in a Private Hospital in Gresik, Indonesia: Pilot Studies

  2024cites this paper
• Is Type and Grade of Emphysema Important for Bone Mineral Density and Aortic Calcifications?

  2024cites this paper
• Metabolomic Analysis of Respiratory Epithelial Lining Fluid in Patients with Chronic Obstructive Pulmonary Disease—A Systematic Review

  2023cites this paper
• Correlation analysis between inflammatory biomarkers and significant clinical phenotypes of chronic obstructive pulmonary disease

  2023cites this paper
• Polypharmacy Management in a Gender Perspective: At the Heart of the Problem: Analysis of Major Cardiac Diseases, SARS-CoV-2 Affection and Gender Distribution in a Cohort of Patients in Internal Medicine Ward

  2023cites this paper
• Phenotype of COPD: “Frequent exacerbator” and Biomarkers Use in Clinical Practice

  2023influential citation
• COPD deaths attributable to ozone in 2019 and future projections using the WHO AQG 2021 in urban China

  2022cites this paper
• Identification of biomarkers in COPD by metabolomics of exhaled breath condensate and serum/plasma.

  2022cites this paper
• Computed Tomography Registration-Derived Regional Ventilation Indices Compared to Global Lung Function Parameters in Patients With COPD

  2022cites this paper
• Body Mass Index Association with Airflow Obstruction in Asian Population: A Retrospective Study

  2022cites this paper
• A nationwide analysis on the effects of chronic obstructive pulmonary disease following primary total shoulder arthroplasty for glenohumeral osteoarthritis

  2021cites this paper
• International Journal of Electrical and Computer Engineering (IJECE)

  2021cites this paper
• Role of Indian Herbal Medicine in the Treatment of Pulmonary Diseases

  2021cites this paper
• Metabolomic profiling of exhaled breath condensate and plasma/serum in chronic obstructive pulmonary disease.

  2021cites this paper
• Determinant Factor of Pulmonary Function Impairment on Rice Mill Workers

  2020cites this paper
• Chronic obstructive pulmonary disease phenotypes: imprint on pharmacological and non-pharmacological therapy

  2020cites this paper
• Emerging Role of Precision Medicine in the Diagnosis and Treatment of Chronic Respiratory Disease

  year unknowncites this paper
• Effect of Inhaler Technique Health Education in Improving Symptoms and Lung Function in COPD Outpatient in a Private Hospital in Gresik, Indonesia: Pilot Studies

  year unknowncites this paper